Cue Health Inkomsten in het verleden
We zijn nog bezig met het verwerken van het laatste winstrapport van dit bedrijf
Verleden criteriumcontroles 0/6
Cue Health's earnings have been declining at an average annual rate of -73.7%, while the Medical Equipment industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 1% per year.
Belangrijke informatie
-73.7%
Groei van de winst
-6.2%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.9% |
| Inkomstengroei | 1.0% |
| Rendement op eigen vermogen | -149.2% |
| Nettomarge | -526.5% |
| Laatste winstupdate | 31 Dec 2023 |
Recente prestatie-updates uit het verleden
Recent updates
Take Care Before Jumping Onto Cue Health Inc. (NASDAQ:HLTH) Even Though It's 26% Cheaper
May 10
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%
Mar 22Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%
Jan 28We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate
Jan 06Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%
Nov 10These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat
Aug 14Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?
Jul 12Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)
May 15Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%
Mar 21We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully
Mar 12Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price
Feb 13Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%
Nov 18Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation
Oct 30Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test
Oct 04Cue Health appoints chief medical oficer
Sep 08Opbrengsten en kosten
Hoe Cue Health geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Dec 23 | 71 | -373 | 90 | 0 |
| 30 Sep 23 | 199 | -257 | 112 | 0 |
| 30 Jun 23 | 251 | -276 | 133 | 0 |
| 31 Mar 23 | 329 | -291 | 153 | 0 |
| 31 Dec 22 | 483 | -194 | 186 | 0 |
| 30 Sep 22 | 529 | -138 | 192 | 0 |
| 30 Jun 22 | 683 | -67 | 187 | 0 |
| 31 Mar 22 | 733 | 34 | 157 | 0 |
| 31 Dec 21 | 618 | 33 | 109 | 0 |
| 30 Sep 21 | 439 | -11 | 72 | 0 |
| 30 Jun 21 | 220 | -24 | 37 | 0 |
| 31 Mar 21 | 87 | -37 | 27 | 0 |
| 31 Dec 20 | 23 | -47 | 25 | 0 |
| 31 Dec 19 | 7 | -21 | 6 | 0 |
Kwaliteitswinsten: HLTH is currently unprofitable.
Groeiende winstmarge: HLTH is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: HLTH is unprofitable, and losses have increased over the past 5 years at a rate of 73.7% per year.
Versnelling van de groei: Unable to compare HLTH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: HLTH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.3%).
Rendement op eigen vermogen
Hoge ROE: HLTH has a negative Return on Equity (-149.24%), as it is currently unprofitable.